Skip to content

Gross margin at other companies

Danaher logo
DanaherDHR
58.9%-0.8pp
Azenta logo
AzentaAZTA
40%-1.0pp
LeMaitre Vascular logo
LeMaitre VascularLMAT
72.4%+3.6pp
TEC
Bio-TechneTECH
65%-0.8pp
CryoPort, Inc. logo
CryoPort, Inc.CYRX
47.2%+1.6pp
Baxter International logo
Baxter InternationalBAX
30.1%-5.9pp

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation

See full
Market cap$1.25B+23.8%
Enterprise value$1.24B+28.3%
P/S12.5×-0.4×

Profitability

See full
Operating margin-16.7%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio7.3×+2.6×

Where this comes from

Calculated from BioLife Solutions’s reported figures.

Based on trailing twelve months.

The official record: BioLife Solutions’s 10-Q, filed May 8, 2025, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's gross margin?
BioLife Solutions (BLFS) reported gross margin of 66.9% in Q1 2025.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.